O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.
about
Acquisition and loss of virulence-associated factors during genome evolution and speciation in three clades of Bordetella speciesBordetella parapertussis Circumvents Neutrophil Extracellular Bactericidal Mechanisms.Bordetella parapertussis outbreak in Southeastern Minnesota and the United States, 2014.Antigenic Variation among Bordetella: Bordetella bronchiseptica strain MO149 expresses a novel o chain that is poorly immunogenic.Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.Bordetella parapertussis PagP mediates the addition of two palmitates to the lipopolysaccharide lipid A.Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- miceA recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis.Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide O antigen.Bordetella parapertussis survives inside human macrophages in lipid raft-enriched phagosomesThe O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussisLack of cross-protection against Bordetella holmesii after pertussis vaccination.Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis.Outer-Membrane-Vesicle-Associated O Antigen, a Crucial Component for Protecting Against Infection
P2860
Q28828144-FF4C8AD8-E516-42D1-AA18-90505FCF4E45Q30354234-118FB6D2-6D7C-4B6C-8C5C-2BB8E42FEF3DQ33714314-684BE502-F666-4DDF-B473-000A2FEEADD8Q34094342-51348F7E-E635-45D5-BEF5-437DBB76D8E3Q34484529-14EE0D79-7ED4-496B-B9A1-0B0BF8046714Q34853638-A3ACCFFF-37A5-486C-AC2E-9AA8E32D9BEEQ36746359-F5A122B4-A613-48BB-9B7A-E62E8A308A7FQ40073161-1A8C54B2-FD7F-4EE0-9EFF-F1FE665381EAQ41174683-63B2DB19-9739-426B-AC9C-585251523B9EQ41721950-FC6D70CA-F0AE-4876-BE2D-2F414569690BQ42613134-33C0AD87-4793-4280-8888-2260A921F9AFQ43078103-24313DD5-4294-475D-A806-0A8829CD9FFEQ53477986-8F243E27-33E2-4AF9-A1FE-30637A1CD7ACQ59136336-BA4D0D15-D395-49D9-A783-E3E4998461E4
P2860
O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
O antigen allows B. parapertus ...... of cross-reactive antibodies.
@ast
O antigen allows B. parapertus ...... of cross-reactive antibodies.
@en
type
label
O antigen allows B. parapertus ...... of cross-reactive antibodies.
@ast
O antigen allows B. parapertus ...... of cross-reactive antibodies.
@en
prefLabel
O antigen allows B. parapertus ...... of cross-reactive antibodies.
@ast
O antigen allows B. parapertus ...... of cross-reactive antibodies.
@en
P2093
P2860
P1433
P1476
O antigen allows B. parapertus ...... of cross-reactive antibodies.
@en
P2093
Eric T Harvill
Maria Eugenia Rodríguez
Xuqing Zhang
P2860
P356
10.1371/JOURNAL.PONE.0006989
P407
P577
2009-09-14T00:00:00Z